Cerebral glucose metabolism in patients with frontotemporal dementia

Journal of Nuclear Medicine

Volumn 39, Issue 11, 1998, Pages 1875-1878

  Ishii, Kazunari ^a,b   Sakamoto, Setsu ^a   Sasaki, Masahiro ^a   Kitagaki, Hajime ^a   Yamaji, Shigeru ^a   Hashimoto, Mamoru ^a   Imamura, Toru ^a   Shimomura, Tatsuo ^a   Hirono, Nobutsugu ^a   Mori, Etsuro ^a  

^a Hyogo Inst Aging Brain Cogn D   (Japan)

^b Hyogo Inst Aging Brain Cogn D   (Japan)

Author keywords

Alzheimer's disease; Cerebral metabolic rate for glucose; Fluorodeoxyglucose; Frontotemporal dementia; PET

Indexed keywords

FLUORODEOXYGLUCOSE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BASAL GANGLION; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DEMENTIA; DIFFERENTIAL DIAGNOSIS; FEMALE; GLUCOSE BRAIN LEVEL; GLUCOSE METABOLISM; HIPPOCAMPUS; HUMAN; MALE; MENTAL HEALTH; METABOLIC RATE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; STATISTICAL ANALYSIS; THALAMUS;

AGED; ALZHEIMER DISEASE; BRAIN; CASE-CONTROL STUDIES; DEMENTIA; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; FRONTAL LOBE; GLUCOSE; HUMANS; MALE; RADIOPHARMACEUTICALS; TEMPORAL LOBE; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0031742412     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Brun A, Englund B, Gustafson L, et al. Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 1994;57:416-418.
2. Neary D, Snowden JS, Bowen DM, et al. Neuropsychological syndromes in presenile dementia due to cerebral atrophy. J Neurol Neurosurg Psychiatry 1986;49:163-174.
3. Neary D, Snowden JS, Northern B, Goulding P. Dementia of frontal lobe type. J Neurol Neurosurg Psychiatry 1988;51:353-361.
4. Gustafson L. Frontal lobe degeneration of non-Alzheimer type. II. Clinical picture and differential diagnosis. Arch Gerontol Geriatr 1987;6:209-223.
5. Mendez M, Selwood A, Mastri A, Frey II W. Pick's disease versus Alzheimer's disease: a comparison of clinical characteristics. Neurology 1993;43:289-292.
6. Gustafson L, Nilsson L. Differential diagnosis of presenile dementia on clinical grounds. Acta Psychiatr Scand 1982;65:194-209.
7. Stuss DT. Assessment of neuropsychological dysfunction in frontal lobe degeneration. Dementia 1993;4:220-225.
8. Johanson A, Hagberg B. Psychometric characteristics in patients with frontal lobe degeneration of non-Alzheimer's type. Arch Gerontol Geriatr 1989;8:129-137.
9. Knopman DS, Christensen KJ, Schut LJ, et al. The spectrum of imaging and neuropsychological findings in Pick's disease. Neurology 1989;39:362-368.
10. Kitagaki H, Mori E, Hirono N, et al. Alteration of white matter MR signal intensity in frontotemporal dementia. AJNR 1997;18:367-378.
11. Kaufer DI, Miller BL, Itti L, et al. Midline cerebral morphometry distinguishes frontotemporal dementia and Alzheimer's disease. Neurology 1997;48:978-985.
12. Ernst T, Chang L, Melchor R, Mehringer CM. Frontotemporal dementia and early Alzheimer's disease: differentiation with frontal lobe H-1 MR spectroscopy. Radiology 1997;203:829-836.
13. Miller BL, Ikonte C, Ponton M, et al. A study of the Lund-Manchester research criteria for frontotemporal dementia: clinical and single-photon emission CT correlations. Neurology 1997;48:937-942.
14. 99mTc-HMPAO in the investigation of dementia. J Neurol Neurosurg Psychiatry 1987;50:1101-1109.
15. Kamo H, McGeer PL, Harrop R, et al. Positron emission tomography and histopathology in Pick's disease. Neurology 1987;37:439-445.
16. Salmon E, Franck G. Positron emission tomographic study in Alzheimer's disease and Pick's disease. Arch Gerontol Geriatr 1989;(suppl 1):241-247.
17. 99mTc-HMPAO SPECT studies with PET in dementia. Ann Nucl Med 1990;4:75-82.
18. Risberg J, Passant U, Warkentin S, Gustafson L. Regional cerebral blood flow in frontal lobe dementia of non-Alzheimer's type. Dementia 1993;4:186-187.
19. Goto I, Taniwaki T, Hosokawa S, Otsuka M, Ichiya Y, Ichimiya A. Positron emission tomographic (PET) studies in dementia. J Neurol Sci 1993;114:1-6.
20. Starkstein SE, Migliorelli R, Tesón A, et al. Specificity of changes in cerebral blood flow in patients with frontal lobe dementia. J Neurol Neurosurg Psychiatry 1994;57: 790-796.
21. Kuwabara Y, Ichiya Y, Ichimiya A, et al. The relationship between the cerebral blood flow, oxygen consumption and glucose metabolism in primary degenerative dementia Jpn J Nucl Med (Kaku Igaku) 1995;32:253-236.
22. Venneri A, Grassi F, Caffarra P, et al. Dementia of frontal lobe type: report of the neuroimaging and neuropsychological results of a case study. Dementia 1996;7:155-160.
23. Miller BL, Cummings JL, Villanueva-Meyer J, et al. Frontal lobe degeneration: clinical, neuropsychological, and SPECT characteristics. Neurology 1991;41:1374-1382.
24. Habert MO, Spampinato U, Mas JL, et al. A comparative technetium-99m hexamethyl propyleneamine oxime SPECT study in different types of dementia. Eur J Nucl Med 1991;18:3-11.
25. Launes J, Sulkava R, Erkinjuntti T, et al. Technetium-99m-HMPAO SPECT in suspected dementia. Nucl Med Comm 1991;12:757-765.
26. Pickut BA, Saerens J, Mariën P, et al. Discriminative use of SPECT in frontal lobe-type dementia versus (senile) dementia of Alzheimer's type. J Nucl Med 1997;38:929-934.
27. Edwards-Lee T, Miller BL, Benson DF, et al. The temporal variant of frontotemporal dementia. Brain 1997;120:1027-1040.
28. Mori E, Mitani Y, Yamadori A. Usefulness of Japanese version of the Mini-Mental State test in neurological patients. Jpn J Neuropsychiatry 1985;1:82-90.
29. World Health Organization. The ICD-10 classification of mental and behavioural disorders. Geneva, Switzerland: World Health Organization; 1992.
30. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan E. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
31. Ishii K, Sasaki M, Sakamoto S, Kitagaki H, Yamaji S, Maeda K. Regional difference of cerebral blood flow and oxidative metabolism in human cortex. J Nucl Med 1996;37:1086-1088.
32. Ishii K, Sasaki M, Kitagaki H, et al. Reduction of cerebellar glucose metabolism in advanced Alzheimer's disease. J Nucl Med 1997;38:925-928.
33. Iida H, Miura S, Kanno I, Murakami M, Yamamoto S, Amano M. Design of evaluation of Headtome IV: a whole-body positron emission tomograph. IEEE Trans Nucl Sci 1989;NS-37:1006-1010.
34. 18F)2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol 1979;6:371-88.
35. Mann DMA, South PW. The topographic distribution of brain atrophy in frontal lobe dementia. Acta Neuropathol 1993;85:334-340.
36. Mann DMA, South PW, Snowden JS, Neary D. Dementia of frontal lobe type: neuropathology and immunohistochemistry. J Neurol Neurosurg Psychiatry 1993;56: 605-614.
37. Lang AE, Bergeron C, Pollanen MS, Ashby P. Parietal Pick's disease mimicking cortical-basal ganglionic degeneration. Neurology 1994;44:1436-1440.
38. Fukui T, Sugita K, Kawamura M, Shiota J, Nakano I. Primary progressive apraxia in Pick's disease: a clinicopathologic study. Neurology 1996;47:467-473.
39. Jackson M, Lowe J. The new neuropathology of degenerative frontotemporal dementias. Acta Neuropathol 1996;91:127-134.